Estee Gold Feet Tbk. vs Merck Tbk. — how do they compare? Estee Gold Feet Tbk. trades at Rp1,740 (market cap 4.42T, 30.4K 24h volume), while Merck Tbk. trades at Rp3,850 (market cap 1.7T, 24.6K 24h volume). The key difference: Estee Gold Feet Tbk. is far larger — about 2.6× Merck Tbk.'s market cap, and Estee Gold Feet Tbk. is more actively traded (30.4K versus 24.6K). Which is the better fit depends on your goals.
| EURO | MERK | |
|---|---|---|
Market Cap | 4.42T | 1.7T |
Volume | 30.4K | 24.6K |
Lot | 304 | 246 |
Turnover | 53.06M | 94.38M |
Average Price | 1,745.54 | 3,836.59 |
Value | 53.06M | 94.38M |
Indicative Equilibrium Price | — | 3,850 |
Indicative Equilibrium Volume | — | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Estee Gold Feet Tbk (Company) was established by Notarial Deed No. 32 dated January 21, 1980 from Abdoel Sjoekoer, S.H., Notary in Jakarta. The Company started its commercial operations in 1986. The Company is controlled by its immediate parent company, PT Timmsvale, a company domiciled in Indonesia. The ultimate beneficial owners of the Company are Johansen Ngian.
Read more on EURO →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →